Skip to main content
Caplight Logo









Filterlex Medical

Filterlex Medical

Private
CaesareaHealthcare & Life Scienceshttps://filterlex.com/

Last Round

Early Funding

Dec 21, 2021

Total Funding Raised

$11.5M

Company Overview

Filterlex Medical is a medical device company that develops the CAPTIS, a full-body embolic protection device designed to reduce the risk of stroke and other complications during catheter-based structural heart procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

embolic protectiontranscatheter heart valve replacementTAVRinterventional cardiologymedical devicestroke preventioncardiovascular devicecatheter-based deviceembolic protection deviceEPDclinical trialscath lab equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Filterlex Medical Comparables

Compare Filterlex Medical with similar companies based on industry and business-model similarity.

Filterlex Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transverse Medical
93%
Emblok
92%
Protembis GmbH
92%

Filterlex Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 21, 2021
Series A ExtensionNov 18, 2021
GrantSep 16, 2019
Series AJul 16, 2019
GrantMay 1, 2019
Accelerator
Jun 1, 2016

Key People

Founding team and executive leadership

Eyal Teichman

Co-Founder CTO

Founding Team

Filterlex Medical Investors

Notable investors and investment history

Filterlex Medical investors
InvestorRounds
Alon Medtech VenturesAccelerator
The Jon DeHaan FoundationGrant
European Innovation Council (EIC) AcceleratorEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Web traffic grew 2727% MoM (from 74 to 2.1K monthly visitors)

  • Nov 18, 2021

    Raised $6M in Series A Extension funding.

Filterlex Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Filterlex Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Filterlex Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCaesarea
Employee Range6
Year Founded2016
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?